Product Liability Lawsuit Funding: How to Get Cash While Your Defective Product Case Is Pending

When a defective product injures someone, the law holds manufacturers, distributors, and retailers accountable through product liability law. Unlike most personal injury claims, which require proving someone acted carelessly, product liability cases can sometimes be pursued under a strict liability theory -- meaning the company can be held responsible simply because the product was defective, regardless of whether they were aware of the problem.

Product liability cases fall into three main categories. The first is a design defect, where the product was dangerous from the outset because of how it was conceived and engineered. A well-known example is a vehicle with a center of gravity so high that normal highway driving makes it prone to rollovers. The second category is a manufacturing defect, where the design itself was sound but something went wrong during production -- for instance, a batch of medication contaminated with a harmful substance at the facility level. The third is failure to warn, also called a marketing defect, which occurs when a company fails to adequately disclose known risks to consumers or prescribing physicians. Many pharmaceutical lawsuits fall into this category: the drug may be effective, but the manufacturer concealed or downplayed dangerous side effects discovered during clinical trials.

These distinctions matter for your lawsuit because they shape how your attorney builds the case, which documents need to be produced in discovery, and which expert witnesses will be required. In practice, many product liability claims involve all three theories simultaneously. If you were injured by a defective medical implant, for example, your attorney might argue that the device had a fundamental design flaw, that the specific unit you received was improperly manufactured, and that the company failed to warn surgeons about risks it had already observed in its own post-market surveillance data. The more complex the theory, the longer the case typically takes to build and resolve -- which is exactly why so many product liability plaintiffs find themselves in severe financial difficulty long before their case is anywhere near a resolution.

If you have been injured by a defective product, you are likely anxious to resolve your case and move forward. The frustrating reality is that product liability litigation is among the slowest categories of personal injury law, and understanding why can help you plan accordingly.

Corporate defendants in product liability cases are typically large companies with enormous legal resources. A major consumer goods manufacturer, a pharmaceutical company, or a medical device maker will retain top-tier defense firms and fight aggressively at every stage of litigation. Discovery alone -- the process of exchanging documents, internal emails, engineering test results, regulatory filings, and corporate communications -- can take two to three years in complex product cases. Your attorney may need to depose dozens of corporate employees, current and former, as well as multiple expert witnesses before the case is positioned for serious settlement negotiations or trial.

Many product cases are also consolidated into what are called Multi-District Litigations, or MDLs. An MDL is formed when thousands of plaintiffs file similar lawsuits against the same defendant over the same product, and a federal panel transfers all of those cases to a single judge to manage pretrial proceedings efficiently. MDLs are common in pharmaceutical litigation, medical device cases, and consumer product recalls. While the MDL structure is designed to improve efficiency, these proceedings still routinely take five to ten years from initial formation to final resolution. If you are one of 50,000 plaintiffs in an MDL involving a dangerous drug or a recalled joint implant, your individual case is largely on hold while bellwether trials and global settlement negotiations play out at the consolidated level.

Finally, insurance companies and corporate legal teams understand that financial pressure on plaintiffs is one of their most powerful tools. If you are struggling to pay your mortgage, your medical bills, and your daily living expenses, you become far more likely to accept a settlement offer that is substantially below what your claim is actually worth. Delay is not accidental in these cases -- it is a deliberate strategy, and it works. Pre-settlement funding exists precisely to neutralize that strategy.

The injuries that product liability cases involve are often among the most severe across all of personal injury law. A defective power tool can cause amputations. A poorly engineered vehicle safety system can result in traumatic brain injury or paralysis. A pharmaceutical drug with concealed risks can cause organ failure, aggressive cancer, or permanent neurological damage. These are not minor injuries with short recovery periods -- they are life-altering events that generate extraordinary medical costs and prolonged inability to work.

Consider a realistic example. You underwent hip replacement surgery with a metal-on-metal implant that was later recalled after it was found to shed metallic particles into surrounding tissue, causing severe tissue death and bone loss. Your revision surgery cost $110,000. You spent five months in rehabilitation. You missed seven months of work as an operations manager earning $80,000 per year. That is a financial deficit of approximately $157,000 before accounting for ongoing medical monitoring, potential future procedures, and the significant pain and suffering you have endured. Your case may ultimately be worth $350,000 or more, but if the MDL is still two to three years from producing any settlement, you are in a serious financial crisis right now.

Most injured plaintiffs exhaust their savings within the first six to twelve months of litigation. Credit cards get maxed out. Retirement accounts get drained. Car payments and mortgages go delinquent. Family relationships fracture under financial stress. And all the while, the defense team is watching -- knowing that when you become desperate enough, you will accept whatever they put on the table just to make it stop. Pre-settlement funding interrupts this cycle by giving you access to a portion of your future settlement proceeds today, allowing you to cover essential expenses and give your attorney the time needed to build and resolve your case properly.

The application process for pre-settlement funding is straightforward, and unlike a bank loan, it requires no credit check, employment verification, proof of income, or collateral. The funding company evaluates your claim, not your personal financial history.

The process begins when you contact a funding company and provide basic information about your case. The company will reach out to your attorney to request relevant case documents -- medical records, the complaint, expert reports if available, and any documentation establishing the defendant's liability. Your attorney needs to cooperate with this process, and most personal injury attorneys who handle product liability cases are well acquainted with pre-settlement funding. It is important to notify your attorney before applying, both as a matter of professional courtesy and because their participation is required to finalize any agreement.

Once the funding company receives your file, an underwriter will assess the strength of your claim. They are primarily evaluating three things: the clarity of liability, the severity and documentation of your damages, and the financial resources of the defendant. A case against a publicly traded pharmaceutical company with documented internal evidence of concealment is going to be evaluated very differently from a case against a small regional manufacturer with a $1 million insurance policy. If your case is approved, you will receive a funding agreement specifying the advance amount and the rate at which it accrues until repayment. If you agree to the terms, funds are typically disbursed within 24 to 48 hours by wire transfer or check.

Repayment happens at the conclusion of your case, directly from your settlement proceeds. Your attorney's office handles the disbursement, paying the funding company's contractual portion before the remaining proceeds are distributed to you. If your case does not settle, if you lose at trial, or if your claim is dismissed, you owe the funding company nothing. The financial risk is entirely theirs, which is why this is called non-recourse funding -- not a loan.

Pre-settlement funding is available across a wide range of product liability claims. While every case is evaluated individually, the following categories represent the most commonly funded types of product liability litigation.

Consumer products is a broad category covering household appliances, power tools, recreational equipment, children's toys, furniture, and clothing. Fires caused by defective lithium-ion batteries in laptops and e-scooters, lacerations from poorly shielded cutting equipment, fall injuries from unstable furniture, and burns from defective pressure cookers are all examples of consumer product cases that regularly receive pre-settlement funding. These cases often involve clear documentation through consumer complaint databases, recall notices, and CPSC investigations.

Pharmaceutical and dangerous drug cases are among the most complex and high-value product liability claims in the legal system. These cases typically involve drugs that were approved by the FDA but later found to cause severe side effects -- including cancers, cardiovascular events, birth defects, or liver failure -- that the manufacturer knew about or should have known about before broad commercialization. Cases involving blood thinners with inadequate dosing guidance, antidepressants linked to neonatal complications, chemotherapy drugs causing permanent nerve damage, and diabetes medications associated with kidney failure have all generated substantial multi-plaintiff litigation. Because pharmaceutical defendants fight these cases aggressively and they almost always proceed through MDL, timelines are long and funding is frequently needed.

Medical device cases represent another major category. Defective hip implants, hernia mesh products, transvaginal mesh, IVC filters, pacemaker leads, and spinal cord stimulators have all been the subject of major product liability litigation in recent years. Because these devices are surgically implanted, the injuries can be catastrophic and the revision surgeries extremely costly. Medical device cases are often strong candidates for pre-settlement funding because the defendants are typically large, well-capitalized companies, and the damages are thoroughly documented in surgical records, imaging studies, and pathology reports.

Motor vehicle product liability cases cover defective brakes, airbag inflators, fuel systems, seat belts, tires, and structural components. These cases often arise alongside auto accident claims but are distinct in targeting the vehicle manufacturer rather than another driver. Regulatory investigations, recall notices, and NHTSA data often provide strong liability documentation, making these cases relatively straightforward to evaluate for funding purposes.

Understanding what underwriters look for can help you assess your likelihood of approval and prepare a stronger application.

The most important factor is liability. The funding company needs reasonable confidence that the defendant is responsible for your injury and that this can be established. Strong indicators include an FDA recall or safety communication, a CPSC or NHTSA investigation, prior jury verdicts against the same defendant for the same product, regulatory correspondence showing the company received adverse event reports, or internal documents produced in discovery. Cases where liability is clear and well-supported by independent evidence are more likely to be approved and may qualify for larger advances.

The second key factor is documented damages. Your medical records need to show that you sustained a serious injury and received meaningful treatment. Funding companies want to see hospitalizations, surgeries, specialist consultations, and any physician opinions about future treatment requirements. Cases that combine substantial economic damages -- documented lost wages, out-of-pocket medical expenses, future care costs -- with significant pain and suffering claims tend to be evaluated most favorably. Incomplete or disorganized medical documentation is one of the most common reasons applications are delayed or approved for less than requested.

The defendant's financial profile is equally important. A case against a company with $5 billion in annual revenue and a well-funded product liability insurance program is a very different risk than a case against a small regional supplier with minimal coverage. Funding companies will research the defendant's assets and insurance before committing capital. This is one reason why cases in major pharmaceutical and medical device MDLs, despite their long timelines, can often be funded at meaningful amounts -- the defendants are almost always large, solvent companies with substantial resources to pay settlements.

Finally, underwriters consider where the case stands procedurally. A case filed last month with no activity beyond the complaint will be harder to evaluate than one where discovery is underway and your attorney can provide a realistic settlement range based on comparable verdicts and settlements. This does not mean you should wait to apply -- many plaintiffs apply early and are approved -- but cases with some litigation history are easier to underwrite with confidence.

Will taking funding hurt my case? No. Pre-settlement funding companies are third-party financiers, not parties to your lawsuit. The defendant and their legal team generally have no way of knowing whether you received funding, and it has no legal effect on your claims, your attorney's strategy, or any settlement negotiations. Your attorney retains complete and exclusive control over all case decisions.

Does my attorney need to approve the funding? Your attorney does not technically approve or disapprove your decision to seek funding -- that decision is yours. However, they do need to cooperate with the application process by providing case documents, and they will need to sign an acknowledgment letter when you finalize the agreement. This is standard practice in the industry. The vast majority of personal injury attorneys who handle product liability cases are fully familiar with pre-settlement funding. If your attorney has concerns about a specific company or agreement, a reputable funding provider will be glad to address those concerns directly.

What if my case is part of an MDL? Funding is available for MDL cases, and many product liability plaintiffs in consolidated proceedings do receive advances. The evaluation may involve more conservatism given the extended timeline and the fact that individual plaintiff settlement values often are not determined until late in the MDL process. Funding amounts for MDL cases tend to be based on a conservative estimate of eventual value rather than a firm projection. That said, many of the most commonly funded case types -- pharmaceutical litigation, medical device recalls -- proceed through MDL almost by definition, and experienced funding companies have well-developed frameworks for evaluating them.

How much will this cost? It is important to be clear-eyed about cost. Pre-settlement funding is not cheap, and it should not be treated as a first resort. Most companies charge a monthly rate that compounds over the life of the advance, typically between 2% and 4% per month. On a $10,000 advance held for 24 months at 3% per month compounding, you would owe approximately $19,700 at repayment -- nearly double the original advance. This is a significant cost, and you should borrow only what you genuinely need to maintain financial stability. That said, if the alternative is accepting a $90,000 settlement offer on a case worth $300,000 because you cannot afford to wait any longer, the cost of funding may represent an exceptional return on that investment.

Borrow only what you actually need. Because funding costs accrue over time, keeping your advance amount as small as possible will meaningfully reduce what you owe at repayment. Before applying, take an honest accounting of your monthly financial shortfall -- what you cannot cover with your current income -- and request only that amount. A disciplined approach to borrowing is the single most effective way to manage the cost of pre-settlement funding.

Be transparent with the funding company. If your case is in MDL, if there are health insurer liens that will need to be resolved at settlement, or if your attorney anticipates a timeline of more than three years, share that information during the application process. Reputable funders want to structure agreements that work for both sides, and accurate information leads to better underwriting and fewer surprises when your case resolves.

Read the agreement carefully before signing. Understand whether the rate is simple or compound, how frequently it accrues, and whether there are administrative fees beyond the stated rate. Ask your attorney to review the agreement with you if anything is unclear. Legitimate funding companies will provide a clear, plain-language summary of total costs at various settlement timeframes and will answer every question you have before you sign.

Stay actively engaged with your attorney throughout your case. Pre-settlement funding gives you the financial runway to wait for a fair settlement -- but only if your attorney is actively working your case. Check in regularly, understand what stage of litigation you are in, and make sure your attorney knows you are positioned to be patient. That patience is frequently the decisive factor between a lowball offer and a settlement that genuinely reflects the harm you have suffered.

Product liability cases pit injured individuals against corporations with enormous legal resources, deep pockets, and a strategic incentive to delay. The injuries involved are often catastrophic, the timelines are long, and the financial pressure on plaintiffs is by design. Pre-settlement funding cannot accelerate your case, but it can remove the desperation that leads so many people to settle for a fraction of what their claim is worth.

If you are pursuing a product liability case -- involving a defective consumer product, a dangerous drug, a recalled medical device, or a faulty vehicle component -- and financial pressure is making it hard to wait for a fair outcome, pre-settlement funding is worth exploring. Levalera works with product liability plaintiffs across the country to provide fast, transparent funding with no upfront costs, no credit requirements, and no obligation whatsoever if your case does not succeed. Contact Levalera today to find out whether your case qualifies and how much you may be able to receive.